Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Archives
    • Special Collections
    • Abstracts In Press
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Archives
    • Special Collections
    • Abstracts In Press
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence

Karen L. Margolis, A. Lauren Crain, Pamala A. Pawloski, Jeanette Y. Ziegenfuss, Nicole K. Trower, Anna R. Bergdall, MarySue Beran, Christine K. Norton, Patricia K. Haugen, Daniel J. Rehrauer, Beverly B. Green, Leif I. Solberg and JoAnn M. Sperl-Hillen
The Journal of the American Board of Family Medicine March 2025, 38 (2) 312-329; DOI: https://doi.org/10.3122/jabfm.2024.240288R1
Karen L. Margolis
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Lauren Crain
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamala A. Pawloski
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanette Y. Ziegenfuss
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole K. Trower
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna R. Bergdall
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MarySue Beran
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine K. Norton
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia K. Haugen
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Rehrauer
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly B. Green
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leif I. Solberg
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JoAnn M. Sperl-Hillen
From the HealthPartners Institute, Minneapolis, MN (KLM, ALC, PAP, JYZ, NKT, ARB, MSB, CKN, LIS, JMSH); HealthPartners, Minneapolis, MN (DJR); Kaiser Permanente Washington Research Institute, Seattle, WA (BBG).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Questions to assess blood pressure medication side effect symptoms.

  • Figure 2.
    • Download figure
    • Open in new tab
    Figure 2.

    (A) Association between side effect symptom severity (somewhat/moderate problem vs. big/very big problem) and blood pressure treatment dissatisfaction. (B) Association between perceived relatedness to medication (related vs. unrelated) and blood pressure treatment dissatisfaction.

  • Figure 3.
    • Download figure
    • Open in new tab
    Figure 3.

    (A) Association between side effect symptom severity (somewhat/moderate problem vs. big/very big problem) and adherence to blood pressure treatment (changing or stopping medications due to side effects). (B) Association between perceived relatedness to medication (related vs. unrelated) and adherence to blood pressure treatment (changing or stopping medications due to side effects).

Tables

  • Figures
    • View popup
    Table 1.

    Participant Characteristics by Baseline Survey Response Status (n = 3,071)

    Non-RespondentsRespondentsp
    N1,3521,719
     Age, M (SD)58.3 (14.5)61.7 (14.0)<0.001
     Age <60, n (%)711 (52.6)708 (41.2)<0.001
     Female, n (%)705 (52.1)934 (54.3)0.23
     BMI (kg/m2), M (SD)32.5 (8.1)32.5 (7.8)0.93
    Race
     White, n (%)876 (64.8)1,256 (73.1)<0.001
     Black, n (%)265 (19.6)329 (19.1)0.75
     Asian, n (%)143 (10.6)70 (4.1)<0.001
     All else, n (%)68 (5.0)64 (3.7)0.08
     Diabetes, n (%)340 (25.1)433 (25.2)0.98
     Cardiovascular disease, n (%)192 (14.2)320 (18.6)0.001
     SBP (mm Hg), M (SD)158.1 (16.0)158.0 (14.8)0.82
     DBP (mm Hg), M (SD)93.0 (13.8)90.6 (13.9)<0.001
    Number of BP medications
     0, n (%)235 (17.4)231 (13.4)0.002
     1, n (%)427 (31.6)524 (30.5)0.51
     2, n (%)380 (28.1)520 (30.3)0.19
     3+, n (%)310 (22.9)444 (25.8)0.06
    Drug classes used
     ACE-inhibitor, n (%)402 (29.7)527 (30.7)0.58
     ARB, n (%)294 (21.7)414 (24.1)0.13
     Diuretic, thiazide, n (%)413 (30.5)546 (31.8)0.47
     Diuretic, loop, n (%)82 (6.1)125 (7.3)0.19
     Beta blocker, n (%)466 (34.5)675 (39.3)0.006
     CCB DHP, n (%)342 (25.3)453 (26.4)0.51
    • Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker, BMI, body mass index; CCB, calcium channel blocker; DHP, dihydropyridine.

    • View popup
    Table 2.

    Severity Rating of Each Hypertension Medication Side Effect Symptom Among Patients Reporting Taking Any Blood Pressure Medications in the Prior 6 Months (n = 1,601)

    Not a ProblemSomewhat/ModerateBig/Very Big
    ANY symptom155 (9.7%)828 (51.6%)618 (38.5%)
    Tiredness, n (%)480 (30.0%)828 (51.7%)293 (18.3%)
    Dizziness, n (%)913 (57.0%)570 (35.6%)118 (7.4%)
    Leg swelling, n (%)1,011 (63.1%)435 (27.2%)155 (9.7%)
    Cough, n (%)1,057 (66.0%)431 (26.90%)113 (7.1%)
    Urinary frequency, n (%)709 (44.3%)702 (43.8%)190 (11.9%)
    Sexual symptoms, n (%)1,214 (75.8%)244 (15.2%)143 (8.9%)
    • Notes: Symptom and Severity: The following questions are about common symptoms that may or may not be related to your blood pressure medicine. Please think back over the past 6 months when answering each of the following questions. Options for severity rating were not at all a problem, somewhat of a problem, moderate problem, big problem, or very big problem.

    • View popup
    Table 3.

    Associations Between Severity of Symptoms and Perceived Relatedness to Blood Pressure Medications, Among Those Reporting That at Least One Symptom Was at Least Somewhat of a Problem (n = 1,446)

    Total with SymptomSomewhat/Moderate ProblemBig/Very Big Problemp
    Tiredness1,121828293
     Unrelated to meds919 (82.0%)703 (84.9%)216 (73.7%)<0.001
     Related to meds202 (18.0%)125 (15.1%)77 (26.3%)
    Dizziness688570118
     Unrelated to meds4,537 (65.8%)393 (69.0%)601 (50.8%)<0.001
     Related to meds235 (34.2%)177 (31.0%)58 (49.2%)
    Leg swelling590435155
     Unrelated to meds429 (73.0%)338 (77.7%)91 (58.7%)<0.001
     Related to meds161 (27.0%)97 (22.3%)64 (41.3%)
    Cough544431113
     Unrelated to meds427 (78.5%)358 (83.1%)69 (61.2%)<0.001
     Related to meds117 (21.5%)73 (16.9%)44 (38.9%)
    Urinary frequency892702190
     Unrelated to meds596 (66.8%)469 (66.8%)127 (66.8%)0.99
     Related to meds296 (33.2%)233 (33.2%)63 (33.2%)
    Sexual symptoms387244143
     Unrelated to meds281 (72.6%)181 (74.2%)100 (69.9%)0.36
     Related to meds106 (27.4%)63 (25.8%)43 (30.1%)
    • View popup
    Appendix 1 Table 1.

    Associations Between Severity Ratings of Select Hypertension Medication Side Effect Symptoms and Specific BP Medications Current at the Index Visit, Among Patients Reporting Taking Any Blood Pressure Medications in the Prior 6 Months (n = 1,601)

    Not a ProblemSomewhat/ModerateBig/Very Big
    Tiredness, n (%)
     All480 (30.0%)828 (51.7%)293 (18.3%)
     Not taking beta blocker286 (30.2%)494 (52.1%)168 (17.7%)
     Taking beta blocker194 (29.7%)334 (51.1%)125 (19.1%)
    Cough, n (%)
     All1,057 (66.0%)431 (26.9%)113 (7.1%)
     Not taking ACE inhibitor726 (66.4%)287 (26.2%)81 (7.4%)
     Taking ACE inhibitor331 (65.3%)144 (28.4%)32 (6.3%)
    Leg Swelling, n (%)
     All1,011 (63.1%)435 (27.2%)155 (9.7%)
     Not taking CCB (DHP)770 (66.0%)304 (26.0%)93 (8.0%)
     Taking CCB (DHP)241 (55.5%)131 (30.2%)62 (14.3%)
    Urinary Frequency, n (%)
     All709 (44.3%)702 (43.8%)190 (11.9%)
     Not taking thiazide diuretic479 (44.6%)458 (42.7%)136 (12.7%)
     Taking thiazide diuretic230 (43.6%)244 (46.2%)54 (10.2%)
    Sexual symptoms, n (%)
     All1,214 (75.8%)244 (15.2%)143 (8.9%)
     Not taking thiazide diuretic809 (75.4%)162 (15.1%)102 (9.5%)
     Taking thiazide diuretic405 (76.7%)82 (15.5%)41 (7.8%)
     Not taking beta blocker726 (76.6%)139 (14.7%)83 (8.8%)
     Taking beta blocker488 (74.7%)105 (16.1%)60 (9.2%)
    • Abbreviations: CCB, calcium channel blocker; DHP, dihydropyridine.

    • View popup
    Appendix 1 Table 2.

    Associations Between Symptom Severity and Perceived Relatedness to Medication to Blood Pressure Treatment Dissatisfaction (n = 1,365)

    Symptom SeverityPerceived Relationship to Medications
    Total with SymptomSomewhat or ModerateBig orVery BigpUnrelated to MedsRelated to Medsp
    ANY symptom1,365779586<0.0017376280.001
     Somewhat or very satisfied712 (52.2%)443 (56.9%)269 (45.9%)402 (54.6%)310 (49.4%)
     Neither satisfied nor dissatisfied329 (24.1%)185 (23.7%)144 (24.6%)198 (26.9%)131 (20.9%)
     Somewhat or very dissatisfied324 (23.7%)151 (19.4%)173 (29.5%)137 (18.6%)187 (29.8%)
    Tiredness10607792810.01869191<0.001
     Somewhat or very satisfied533 (50.3%)408 (52.4%)125 (44.5%)454 (52.2%)79 (41.4%)
     Neither satisfied nor dissatisfied265 (25.0%)193 (24.8%)72 (25.6%)222 (25.5%)43 (22.5%)
     Somewhat or very dissatisfied262 (24.7%)178 (22.8%)84 (29.9%)193 (22.2%)69 (36.1%)
    Dizziness6505381120.024222280.006
     Somewhat or very satisfied325 (50.0%)276 (51.3%)49 (43.7%)222 (52.6%)103 (45.2%)
     Neither satisfied nor dissatisfied141 (21.7%)124 (23.0%)17 (15.2%)100 (23.7%)41 (18.0%)
     Somewhat or very dissatisfied184 (28.3%)138 (25.6%)46 (41.1%)100 (23.7%)84 (36.8%)
    Leg swelling5534111420.164011520.003
     Somewhat or very satisfied276 (49.9%)214 (52.1%)62 (43.7%)210 (52.4%)66 (43.4%)
     Neither satisfied nor dissatisfied138 (25.0%)96 (23.4%)42 (29.6%)108 (26.9%)30 (19.7%)
     Somewhat or very dissatisfied139 (25.1%)101 (24.6%)38 (26.8%)83 (20.7%)56 (36.8%)
    Cough5174101070.064031140.03
     Somewhat or very satisfied252 (48.7%)205 (50.0%)47 (43.9%)202 (50.1%)50 (43.9%)
     Neither satisfied nor dissatisfied132 (25.5%)110 (26.8%)22 (20.6%)110 (27.3%)22 (19.3%)
     Somewhat or very dissatisfied133 (25.7%)95 (23.2%)39 (35.5%)91 (22.6%)42 (36.8%)
    Urinary frequency8456681770.415652800.04
     Somewhat or very satisfied410 (48.5%)327 (48.9%)83 (46.9%)280 (49.6%)130 (46.4%)
     Neither satisfied nor dissatisfied219 (25.9%)176 (26.3%)43 (24.3%)161 (28.5%)58 (20.7%)
     Somewhat or very dissatisfied216 (25.6%)165 (24.7%)51 (28.8%)124 (22.0%)92 (32.9%)
    Sexual symptoms3742351390.012711030.04
     Somewhat or very satisfied167 (44.7%)119 (50.6%)48 (34.5%)128 (47.2%)39 (37.9%)
     Neither satisfied nor dissatisfied113 (30.2%)60 (25.5%)53 (38.1%)83 (30.6%)30 (29.1%)
     Somewhat or very dissatisfied94 (25.1%)56 (23.8%)38 (27.3%)60 (22.1%)34 (33.0%)
    • View popup
    Appendix 1 Table 3.

    Associations Between Symptom Severity and Perceived Relatedness to Medication Adherence to Blood Pressure Treatment Adherence (Changing or Stopping Medications Due to Side Effects) and (n = 1,423)

    Symptom SeverityPerceived Related to Medication
    Total with SymptomSomewhat or ModerateBig or Very BigpUnrelated to MedsRelated to Medsp
    Any symptom1,423811612<0.001769654
     No adherence issue1,090 (76.6%)664 (81.9%)426 (69.6%)661 (86.0%)429 (65.6%)<0.001
     Yes adherence issue333 (23.4%)147 (18.1%)186 (30.4%)108 (14.0%)225 (34.4%)
    Tiredness1,1028122900.006905197<0.001
     No adherence issue826 (75.0%)626 (77.1%)200 (69.0%)706 (78.0%)120 (60.9%)
     Yes adherence issue276 (25.0%)186 (22.9%)90 (31.0%)199 (22.0%)77 (39.1%)
    Dizziness675560115<0.001442233<0.001
     No adherence issue467 (69.2%)406 (72.5%)61 (53.0%)336 (76.0%)131 (56.2%)
     Yes adherence issue208 (30.8%)154 (27.5%)54 (47.0%)106 (24.0%)102 (43.8%)
    Leg swelling5834311520.344251,589<0.001
     No adherence issue435 (74.6%)326 (75.6%)109 (71.7%)339 (89.8%)96 (60.8%)
     Yes adherence issue148 (25.4%)105 (24.4%)43 (28.3%)86 (20.2%)62 (39.2%)
    Cough5414281130.06424117<0.001
     No adherence issue392 (72.5%)318 (74.3%)74 (65.5%)323 (76.2%)69 (59.0%)
     Yes adherence issue149 (27.5%)110 (25.7%)39 (34.5%)101 (23.8%)48 (41.0%)
    Urinary frequency8866961900.195922940.08
     No adherence issue662 (74.7%)527 (75.7%)135 (71.0%)453 (76.5%)209 (71.1%)
     Yes adherence issue224 (25.3%)169 (24.3%)55 (29.0%)139 (23.5%)85 (28.9%)
    Sexual symptoms3842421420.07278106<0.001
     No adherence issue278 (72.4%)183 (75.6%)95 (66.9%)214 (77.0%)64 (60.4%)
     Yes adherence issue106 (27.6%)59 (24.4%)47 (33.1%)64 (23.0%)42 (39.6%)
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 38 (2)
The Journal of the American Board of Family Medicine
Vol. 38, Issue 2
March-April 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence
Karen L. Margolis, A. Lauren Crain, Pamala A. Pawloski, Jeanette Y. Ziegenfuss, Nicole K. Trower, Anna R. Bergdall, MarySue Beran, Christine K. Norton, Patricia K. Haugen, Daniel J. Rehrauer, Beverly B. Green, Leif I. Solberg, JoAnn M. Sperl-Hillen
The Journal of the American Board of Family Medicine Mar 2025, 38 (2) 312-329; DOI: 10.3122/jabfm.2024.240288R1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence
Karen L. Margolis, A. Lauren Crain, Pamala A. Pawloski, Jeanette Y. Ziegenfuss, Nicole K. Trower, Anna R. Bergdall, MarySue Beran, Christine K. Norton, Patricia K. Haugen, Daniel J. Rehrauer, Beverly B. Green, Leif I. Solberg, JoAnn M. Sperl-Hillen
The Journal of the American Board of Family Medicine Mar 2025, 38 (2) 312-329; DOI: 10.3122/jabfm.2024.240288R1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Appendix 1.
    • Appendix 2.Blood Pressure Care Survey
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection
  • Effect of Initiating HPV Vaccination Before Age 11 on HPV Vaccination Completion
  • How High-Performing Community Health Clinics Accomplish Social Risk Screening
Show more Original Research

Similar Articles

Keywords

  • Blood Pressure
  • Drug Side Effects
  • Hypertension
  • Patient Adherence
  • Patient Satisfaction
  • Pharmacology
  • Surveys and Questionnaires
  • Symptom Assessment

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2026 American Board of Family Medicine

Powered by HighWire